Luz Luque
Family · Hialeah, FLNPI 1194198622
Payments from drug & device makers
Across 496 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- AstraZeneca$1K
- Amgen$540
- Boehringer Ingelheim$537
- plus $4K from 33 others
What the payments were for
- Food & beverage$9,480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 85 | $1,445 |
| Lilly USA, LLC | 76 | $1,204 |
| Novo Nordisk | 49 | $1,097 |
| AstraZeneca | 39 | $1,005 |
| Amgen | 30 | $540 |
| Boehringer Ingelheim | 30 | $537 |
| Pfizer | 24 | $489 |
| Bayer | 14 | $465 |
| Sanofi-aventis U.S. LLC | 20 | $361 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $305 |
| GSK | 14 | $298 |
| Antares Pharma, Inc. | 20 | $239 |
| Biohaven Pharmaceuticals, Inc. | 16 | $220 |
| Lundbeck LLC | 9 | $213 |
| Exact Sciences | 5 | $108 |
| Merck | 5 | $98 |
| Ironwood Pharmaceuticals, Inc | 4 | $75 |
| Eisai Inc. | 4 | $71 |
| Halozyme Inc | 3 | $66 |
| Biogen | 4 | $63 |
| Dexcom, Inc. | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Esperion Therapeutics, Inc. | 3 | $47 |
| Novartis | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $30 |
| Nabriva Therapeutics, PLC | 2 | $29 |
| Radius Health, Inc. | 1 | $26 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Alvogen Inc | 1 | $23 |
| Axonics, Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Abbott | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $14 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$117
- RYBELSUS$114
- NURTEC ODT$113
- Kerendia$105
How this compares
$9,480 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 27 | $44,891 |
| FarxigaDapagliflozin Propanediol | 26 | $36,356 |
| OzempicSemaglutide | 25 | $25,396 |
| ProliaDenosumab | 13 | $22,313 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 16 | $21,844 |
| TrulicityDulaglutide | 21 | $20,353 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 15 | $19,768 |
| EliquisApixaban | 11 | $10,164 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,045 |
| LivaloPitavastatin Calcium | 13 | $6,792 |
| Kombiglyze XrSaxagliptin Hcl/Metformin Hcl | 11 | $5,245 |
| Memantine Hcl ErMemantine Hcl | 11 | $5,060 |
| SynthroidLevothyroxine Sodium | 34 | $3,634 |
| EdarbiAzilsartan Medoxomil | 12 | $2,804 |
| Omega-3 Acid Ethyl Esters | 24 | $1,163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet Xr | $98 | $66,73543 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,005 | $43,40137 claims |
| Novo NordiskOzempic | $1,097 | $25,39625 claims |
| AmgenProlia | $540 | $22,31313 claims |
| Lilly USA, LLCTrulicity | $1,204 | $20,35321 claims |
| Boehringer IngelheimSynjardy Xr | $537 | $19,76815 claims |
| PfizerEliquis | $489 | $10,16411 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $48 | $6,79213 claims |
| AbbVieSynthroid | $1,445 | $3,63434 claims |
| Arbor Pharmaceuticals, Inc.Edarbi | $37 | $2,80412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Hialeah
- David RodriguezHialeah$658K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.